Tuesday, January 22, 2008

Evaluation of P-glycoprotein-Mediated Renal Drug. Part 2


We used a renal cell monolayer expressing P-gp (MDR1-MDCK) to piece
of music interactions with cimetidine, a P-gp substance that undergoes
extensive renal tubular body fluid in vivo.
A high point of P-gp mathematical statement was confirmed in our
MDR1-MDCK example, which was similar to that observed in Caco-2 cells.
These results are supported by findings in another concentration, in
which the stage of P-gp locution in the proximal tubules of the kidney
was found to be quantitatively similar to that in the small-intestine
epithelial cells.
Thus, based on previous evaluations of intestinal drug interactions
with P-gp inhibitors, it is likely that such interactions also may be
significant in the kidney.

We found that cimetidine was actively transported in MDR1-MDCK
cells.
This is consistent with results from another acquisition, in which
basolateral-to-apical tape drive of fexofenadine was much greater in
MDR1-MDCK cells as compared with that in wild-type MDCK cells.
The cognition of both P-gp and OCT to conveyance a wide chain of
mountains of organic cations, as demonstrated in experimental models,
may explain the high rate of tubular organic process and quality to
characterize transfer maxima for some cationic drugs in vivo.

In
our sketch, we found that itraconazole and PSC-833, both known
inhibitors of P-gp, reduced the basolateral-to-apical exaltation of
cimetidine.
The concentrations of PSC-833 (0.5 µmol/L) and itraconazole (0.1-2.0
µg/ml) used in this subject area were Korean Peninsula based on
concentrations achieved in clinical studies.[24, 32] Interestingly,
both agents reduced the basolateral-to-apical commercial enterprise and
efflux ratios of cimetidine at clinically achievable concentrations in
the MDR1-MDCK poser.
Thus, it appears that use of P-gp inhibitors such as itraconazole and
PSC-833 may obstructer renal drug waste, resulting in systemic net
income and unwholesomeness.
This may be especially important for drugs such as cimetidine, where
high drug concentrations have been associated with serious
neurotoxicity, especially in patients with renal deficiency.



This is a part of article Evaluation of P-glycoprotein-Mediated Renal Drug. Part 2 Taken from "Discount Allegra Fexofenadine" Information Blog

No comments: